Novartis Plans to Align its Production with Expected Lower Prices in the US
Shots:
- Novartis plans to increase its worldwide operating profit margins by making production efficient- in spite of dipping in prices for its drugs in the US
- The company aims to increase efficiency of pharma business from 32% to 35% within five years
- As per Novartis chairman- drug prices are rising in Europe and Novartis can charge slightly higher or stable prices in Europe
- Cuplikan Olahraga
/ article | Ref: Reuters | Image: Novartis
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com